SEC Filing Summary: Synaptogenix, Inc. (SNPX)
Business Context and Reporting Period
This Form 8-K Current Report, dated October 11, 2022, details the results of Synaptogenix, Inc.'s Annual Meeting of Stockholders. The company is an emerging growth company incorporated in Delaware, with its principal executive offices in New York, New York. The filing reports on corporate governance actions and shareholder voting outcomes.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and equity plan amendments.
Material Changes and Voting Results
- Equity Incentive Plan Amendment: Stockholders approved an amendment to the 2020 Equity Incentive Plan, increasing the authorized share pool from 625,000 to 1,375,000 shares of Common Stock.
- Director Elections: Stockholders elected Bruce T. Bernstein and Jonathan L. Schechter to the Board of Directors for terms ending in 2025.
- Accounting Firm Ratification: Stockholders ratified the selection of Morison Cogen LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022.
- Quorum: Approximately 56.32% of outstanding shares (3,853,024 shares) were represented at the meeting.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of specific risks or contingencies. It serves as a procedural record of the Annual Meeting outcomes.
Investor Verification Checklist
- Verify the impact of the increased equity pool (1,375,000 shares) on potential future dilution.
- Review the full text of the Amendment to the 2020 Equity Incentive Plan (Exhibit 10.1) for specific terms.
- Confirm the voting percentages for the director elections, noting the significant number of broker non-votes (2,385,495) for Proposal 1.
- Check subsequent filings for the company's financial status, as this 8-K does not provide current financial metrics.